Drug intelligence / Profile preview

Multimin 90

Development stage
Unknown
Lead developer
Axiota Animal Health
Modality
Small Molecules
Administration
Subcutaneous
01

Overview

Multimin 90 is an FDA-approved veterinary injectable trace mineral product for cattle developed by Multimin North America and marketed under Axiota Animal Health. It is a sterile aqueous subcutaneous injection containing zinc, copper, manganese, and selenium, supplied as zinc oxide, copper carbonate, manganese carbonate, and sodium selenite. The product functions as a **multi-mineral replacement and supplementation therapy**, providing essential trace elements that serve as cofactors for numerous enzymes involved in antioxidant defense, immune function, reproduction, and general metabolic health in cattle rather than acting through a single receptor-mediated pharmacology. It is used to provide a supplemental source of these essential trace minerals in cattle and is positioned as a veterinary mineral injectable with restrictions in certain pregnant animals and young calves.

Brand names
Multimin 90Multimin90Multimin-90
Other names
injectable trace mineral supplementzinc + copper + manganese + selenium

Beyond the preview

Go deeper on Multimin 90.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Multimin 90.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call